BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26067065)

  • 1. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Kimura T; Takahashi S; Takahashi I; Nishibuchi I; Doi Y; Kenjo M; Murakami Y; Honda Y; Aikata H; Chayama K; Nagata Y
    PLoS One; 2015; 10(6):e0125231. PubMed ID: 26067065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function.
    Sanuki-Fujimoto N; Takeda A; Ohashi T; Kunieda E; Iwabuchi S; Takatsuka K; Koike N; Shigematsu N
    Br J Radiol; 2010 Dec; 83(996):1063-71. PubMed ID: 21088090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
    Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
    AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma.
    Takeda A; Oku Y; Sanuki N; Kunieda E; Koike N; Aoki Y; Ohashi T; Iwabuchi S; Takatsuka K; Takeda T; Sugawara A
    Radiother Oncol; 2012 Sep; 104(3):374-8. PubMed ID: 22248506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA.
    Sanuki N; Takeda A; Oku Y; Eriguchi T; Nishimura S; Aoki Y; Mizuno T; Iwabuchi S; Kunieda E
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):306-11. PubMed ID: 24411601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
    Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
    Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
    Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma.
    Nakamura Y; Kimura T; Higaki T; Honda Y; Komoto D; Yamagami T; Iida M; Nagata Y; Honda Y; Aikata H; Chayama K; Awai K
    Jpn J Radiol; 2015 Oct; 33(10):627-35. PubMed ID: 26227061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma.
    Culleton S; Jiang H; Haddad CR; Kim J; Brierley J; Brade A; Ringash J; Dawson LA
    Radiother Oncol; 2014 Jun; 111(3):412-7. PubMed ID: 24906626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
    Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
    Jeong Y; Jung J; Cho B; Kwak J; Jeong C; Kim JH; Park JH; Kim SY; Shim JH; Kim KM; Lim YS; Lee HC; Yoon SM
    BMC Cancer; 2018 Apr; 18(1):416. PubMed ID: 29653562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma.
    Dreher C; Høyer KI; Fode MM; Habermehl D; Combs SE; Høyer M
    Acta Oncol; 2016 Jul; 55(7):886-91. PubMed ID: 26878669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold doses and prediction of visually apparent liver dysfunction after stereotactic body radiation therapy in cirrhotic and normal livers using magnetic resonance imaging.
    Doi H; Shiomi H; Masai N; Tatsumi D; Igura T; Imai Y; Oh RJ
    J Radiat Res; 2016 Jun; 57(3):294-300. PubMed ID: 26983986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.
    Bae SH; Kim MS; Jang WI; Kay CS; Kim W; Kim ES; Kim JH; Kim JH; Yang KM; Lee KC; Chang AR; Jo S
    Jpn J Clin Oncol; 2016 Apr; 46(4):363-9. PubMed ID: 26826720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Meloni F; Invernizzi F; Valsecchi MG; Fazio F
    J Comput Assist Tomogr; 2008; 32(6):855-8. PubMed ID: 19204443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Brade AM; Ng S; Brierley J; Kim J; Dinniwell R; Ringash J; Wong RR; Cho C; Knox J; Dawson LA
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):580-7. PubMed ID: 26867886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration.
    Lee S; Kim H; Ji Y; Cho B; Kim SS; Jung J; Kwak J; Park JH; Lee SW; Kim JH; Yoon SM
    Sci Rep; 2018 Nov; 8(1):16224. PubMed ID: 30385839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization.
    Shirai S; Sato M; Suwa K; Kishi K; Shimono C; Sonomura T; Kawai N; Tanihata H; Minamiguchi H; Nakai M
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1037-44. PubMed ID: 19540053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.